UniProt ID | CCNH_HUMAN | |
---|---|---|
UniProt AC | P51946 | |
Protein Name | Cyclin-H | |
Gene Name | CCNH | |
Organism | Homo sapiens (Human). | |
Sequence Length | 323 | |
Subcellular Localization | Nucleus. | |
Protein Description | Regulates CDK7, the catalytic subunit of the CDK-activating kinase (CAK) enzymatic complex. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Involved in cell cycle control and in RNA transcription by RNA polymerase II. Its expression and activity are constant throughout the cell cycle.. | |
Protein Sequence | MYHNSSQKRHWTFSSEEQLARLRADANRKFRCKAVANGKVLPNDPVFLEPHEEMTLCKYYEKRLLEFCSVFKPAMPRSVVGTACMYFKRFYLNNSVMEYHPRIIMLTCAFLACKVDEFNVSSPQFVGNLRESPLGQEKALEQILEYELLLIQQLNFHLIVHNPYRPFEGFLIDLKTRYPILENPEILRKTADDFLNRIALTDAYLLYTPSQIALTAILSSASRAGITMESYLSESLMLKENRTCLSQLLDIMKSMRNLVKKYEPPRSEEVAVLKQKLERCHSAELALNVITKKRKGYEDDDYVSKKSKHEEEEWTDDDLVESL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MYHNSSQKRHWT ---CCCCCCCCCCCC | 22.34 | 10993082 | |
8 | Ubiquitination | MYHNSSQKRHWTFSS CCCCCCCCCCCCCCC | 48.45 | - | |
8 | 2-Hydroxyisobutyrylation | MYHNSSQKRHWTFSS CCCCCCCCCCCCCCC | 48.45 | - | |
39 | Ubiquitination | CKAVANGKVLPNDPV CEEEECCEECCCCCC | 40.17 | - | |
58 | Ubiquitination | HEEMTLCKYYEKRLL CCHHHHHHHHHHHHH | 54.72 | 29967540 | |
72 | Ubiquitination | LEFCSVFKPAMPRSV HHHHHCCCCCCCCCH | 29.70 | - | |
121 | Phosphorylation | KVDEFNVSSPQFVGN CCCCCCCCCCCHHCC | 37.09 | 23186163 | |
122 | Phosphorylation | VDEFNVSSPQFVGNL CCCCCCCCCCHHCCC | 20.59 | 23186163 | |
132 | Phosphorylation | FVGNLRESPLGQEKA HHCCCCCCCCCHHHH | 20.99 | 25159151 | |
136 | Ubiquitination | LRESPLGQEKALEQI CCCCCCCHHHHHHHH | 57.61 | 33845483 | |
189 | Ubiquitination | ENPEILRKTADDFLN CCHHHHHHHHHHHHH | 44.62 | 33845483 | |
221 | Ubiquitination | LTAILSSASRAGITM HHHHHHHHHHCCCCH | 10.32 | 29967540 | |
227 | Phosphorylation | SASRAGITMESYLSE HHHHCCCCHHHHHHH | 17.61 | 18767875 | |
233 | Phosphorylation | ITMESYLSESLMLKE CCHHHHHHHHHCHHC | 19.53 | 18767875 | |
253 | Ubiquitination | SQLLDIMKSMRNLVK HHHHHHHHHHHHHHH | 41.24 | - | |
262 | Phosphorylation | MRNLVKKYEPPRSEE HHHHHHHHCCCCHHH | 28.13 | - | |
274 | Acetylation | SEEVAVLKQKLERCH HHHHHHHHHHHHHHH | 38.50 | 25953088 | |
274 | Ubiquitination | SEEVAVLKQKLERCH HHHHHHHHHHHHHHH | 38.50 | 29967540 | |
282 | Phosphorylation | QKLERCHSAELALNV HHHHHHHHHHHHHHH | 27.37 | 23898821 | |
297 | Phosphorylation | ITKKRKGYEDDDYVS HHHHCCCCCCCCCCC | 21.15 | 27642862 | |
302 | Phosphorylation | KGYEDDDYVSKKSKH CCCCCCCCCCCCCCC | 17.39 | 28674419 | |
304 | Phosphorylation | YEDDDYVSKKSKHEE CCCCCCCCCCCCCCC | 28.30 | 10993082 | |
305 | Acetylation | EDDDYVSKKSKHEEE CCCCCCCCCCCCCCC | 51.53 | 26051181 | |
306 | Ubiquitination | DDDYVSKKSKHEEEE CCCCCCCCCCCCCCC | 58.17 | - | |
307 | Phosphorylation | DDYVSKKSKHEEEEW CCCCCCCCCCCCCCC | 42.87 | 30266825 | |
315 | Phosphorylation | KHEEEEWTDDDLVES CCCCCCCCCCHHHHC | 32.60 | 19664994 | |
322 | Phosphorylation | TDDDLVESL------ CCCHHHHCC------ | 31.72 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
5 | S | Phosphorylation | Kinase | CDK8 | P49336 | Uniprot |
304 | S | Phosphorylation | Kinase | CDK8 | P49336 | Uniprot |
315 | T | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
315 | T | Phosphorylation | Kinase | CSNK2A2 | P19784 | GPS |
315 | T | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
315 | T | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CCNH_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCNH_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-315 AND SER-322, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132; SER-307; THR-315AND SER-322, AND MASS SPECTROMETRY. | |
"TFIIH is negatively regulated by cdk8-containing mediatorcomplexes."; Akoulitchev S., Chuikov S., Reinberg D.; Nature 407:102-106(2000). Cited for: PHOSPHORYLATION AT SER-5 AND SER-304, AND MUTAGENESIS OF SER-5 ANDSER-304. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-315, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-315, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-315, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-315, AND MASSSPECTROMETRY. |